196
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Daily Oxygen Supplementation and Risk of Retinopathy of Prematurity

, , , &
Pages 317-325 | Received 23 Feb 2022, Accepted 04 Aug 2022, Published online: 12 Sep 2022

References

  • Solebo AL, Teoh L, Rahi J. Epidemiology of blindness in children [published correction appears in Arch Dis Child. 2017 Oct;102(10):995]. Arch Dis Child. 2017;102(9):853–857. doi:10.1136/archdischild-2016-310532.
  • Blencowe H, Lawn JE, Vazquez T, Fielder A, Gilbert C. Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010. Pediatr Res. 2013;74(Suppl 1):35–49. doi:10.1038/pr.2013.205.
  • Fierson WM. American academy of pediatrics section on ophthalmology; american academy of ophthalmology; american association for pediatric ophthalmology and strabismus; american association of certified orthoptists. screening examination of premature infants for retinopathy of prematurity. [published correction appears in Pediatrics. 2019 Mar;143(3)]. Pediatrics. 2018;142(6):e20183061. doi:10.1542/peds.2018-3061.
  • Jefferies AL. Canadian paediatric society, fetus and newborn committee. retinopathy of prematurity: an update on screening and management. Paediatr Child Health. 2016;21(2):101–108. doi:10.1093/pch/21.2.101.
  • Binenbaum G, Tomlinson LA, de Alba Campomanes AG, et al. Validation of the postnatal growth and retinopathy of prematurity screening criteria. [published online ahead of print, 2019 Nov 14] [published correction appears in JAMA Ophthalmol. 2020 Jan 1;138(1):105]. JAMA Ophthalmol. 2019;138(1):31–37.doi:10.1001/jamaophthalmol.2019.4517.
  • Martin JA, Hamilton BE, Osterman MJK, Driscoll AK, Drake P. Births: final data for 2017. Natl Vital Stat Rep. 2018;67:1–50.
  • Early Treatment for Retinopathy of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol. 2003;121:(12). 1684–1694. doi:10.1001/archopht.121.12.1684.
  • Palmer EA, Flynn JT, Hardy RJ, et al. Incidence and early course of retinopathy of prematurity. the cryotherapy for retinopathy of prematurity cooperative group. Ophthalmology. 1991;98(11):1628–1640.doi:10.1016/s0161-6420(91)32074-8.
  • Chiang MF, Arons RR, Flynn JT, Starren JB. Incidence of retinopathy of prematurity from 1996 to 2000: analysis of a comprehensive New York state patient database. Ophthalmology. 2004;111(7):1317–1325. doi:10.1016/j.ophtha.2003.10.030.
  • Quinn GE, Ying GS, Bell EF, et al. Incidence and early course of retinopathy of prematurity: secondary analysis of the postnatal Growth and Retinopathy of Prematurity (G-ROP) study. JAMA Ophthalmol. 2018;136(12):1383–1389.doi:10.1001/jamaophthalmol.2018.4290.
  • Smith LE, Shen W, Perruzzi C, et al. Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor. Nat Med. 1999;5(12):1390–1395.doi:10.1038/70963.
  • Hellström A, Perruzzi C, Ju M, et al. Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity. Proc Natl Acad Sci U S A. 2001;98(10):5804–5808.doi:10.1073/pnas.101113998.
  • Hellström A, Engström E, Hård AL, et al. Postnatal serum insulin-like growth factor I deficiency is associated with retinopathy of prematurity and other complications of premature birth. Pediatrics. 2003;112(5):1016–1020.doi:10.1542/peds.112.5.1016.
  • Smith LE. Pathogenesis of retinopathy of prematurity. Growth Horm IGF Res. 2004;14(Suppl A):S140–S144. doi:10.1016/j.ghir.2004.03.030.
  • Löfqvist C, Andersson E, Sigurdsson J, et al. Longitudinal postnatal weight and insulin-like growth factor I measurements in the prediction of retinopathy of prematurity [published correction appears in Arch Ophthalmol. 2007 Mar;125(3):426]. Arch Ophthalmol. 2006;124(12):1711–1718.doi:10.1001/archopht.124.12.1711.
  • Löfqvist C, Hansen-Pupp I, Andersson E, et al. Validation of a new retinopathy of prematurity screening method monitoring longitudinal postnatal weight and insulinlike growth factor I. Arch Ophthalmol. 2009;127(5):622–627.doi:10.1001/archophthalmol.2009.69.
  • Wu C, Vanderveen DK, Hellström A, Löfqvist C, Smith LE. Longitudinal postnatal weight measurements for the prediction of retinopathy of prematurity. Arch Ophthalmol. 2010;128(4):443–447. doi:10.1001/archophthalmol.2010.31.
  • Binenbaum G, Ying GS, Quinn GE, et al. A clinical prediction model to stratify retinopathy of prematurity risk using postnatal weight gain. Pediatrics. 2011;127(3):e607–e614.doi:10.1542/peds.2010-2240.
  • Wu C, Löfqvist C, Smith LE, VanderVeen DK, Hellström A. WINROP consortium. importance of early postnatal weight gain for normal retinal angiogenesis in very preterm infants: a multicenter study analyzing weight velocity deviations for the prediction of retinopathy of prematurity. Arch Ophthalmol. 2012;130(8):992–999. doi:10.1001/archophthalmol.2012.243.
  • Eckert GU, Fortes Filho JB, Maia M, Procianoy RS. A predictive score for retinopathy of prematurity in very low birth weight preterm infants. Eye (Lond). 2012;26(3):400–406. doi:10.1038/eye.2011.334.
  • Binenbaum G, Ying GS, Quinn GE, et al. The CHOP postnatal weight gain, birth weight, and gestational age retinopathy of prematurity risk model. Arch Ophthalmol. 2012;130(12):1560–1565.doi:10.1001/archophthalmol.2012.2524.
  • Cao JH, Wagner BD, McCourt EA, et al. The Colorado-retinopathy of prematurity model (CO-ROP): postnatal weight gain screening algorithm. J AAPOS. 2016;20(1):19–24.doi:10.1016/j.jaapos.2015.10.017.
  • Piermarocchi S, Bini S, Martini F, et al. Predictive algorithms for early detection of retinopathy of prematurity. Acta Ophthalmol. 2017;95(2):158–164.doi:10.1111/aos.13117.
  • Binenbaum G, Ying GS, Tomlinson LA; Postnatal Growth and Retinopathy of Prematurity (G-ROP) Study Group. Validation of the Children’s Hospital of Philadelphia Retinopathy of Prematurity (CHOP ROP) Model. JAMA Ophthalmol. 2017;135(8):871–877. doi:10.1001/jamaophthalmol.2017.2295.
  • Binenbaum G, Bell EF, Donohue P, et al. Development of modified screening criteria for retinopathy of prematurity: primary results from the postnatal growth and retinopathy of prematurity study. JAMA Ophthalmol. 2018;136(9):1034–1040.doi:10.1001/jamaophthalmol.2018.2753.
  • Ashton N, Ward B, Serpell G. Effect of oxygen on developing retinal vessels with particular reference to the problem of retrolental fibroplasia. Br J Ophthalmol. 1954;38(7):397–432. doi:10.1136/bjo.38.7.397.
  • Smith LE. Through the eyes of a child: understanding retinopathy through ROP the Friedenwald lecture. Invest Ophthalmol Vis Sci. 2008;49(12):5177–5182. doi:10.1167/iovs.08-2584.
  • Chan-Ling T, Gock B, Stone J. The effect of oxygen on vasoformative cell division. Evidence that ‘physiological hypoxia’ is the stimulus for normal retinal vasculogenesis. Invest Ophthalmol Vis Sci. 1995;36:1201–1214.
  • Hughes S, Yang H, Chan-Ling T. Vascularization of the human fetal retina: roles of vasculogenesis and angiogenesis. Invest Ophthalmol Vis Sci. 2000;41:1217–1228.
  • Stone J, Itin A, Alon T, et al. Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J Neurosci. 1995;15(7 Pt 1):4738–4747.doi:10.1523/JNEUROSCI.15-07-04738.1995.
  • Provis JM, Leech J, Diaz CM, Penfold PL, Stone J, Keshet E. Development of the human retinal vasculature: cellular relations and VEGF expression. Exp Eye Res. 1997;65(4):555–568. doi:10.1006/exer.1997.0365.
  • Alon T, Hemo I, Itin A, Pe’er J, Stone J, Keshet E. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med. 1995;1(10):1024–1028. doi:10.1038/nm1095-1024.
  • Chan-Ling T, Tout S, Holländer H, Stone J. Vascular changes and their mechanisms in the feline model of retinopathy of prematurity. Invest Ophthalmol Vis Sci. 1992;33:2128–2147.
  • Tin W, Wariyar U. Giving small babies oxygen: 50 years of uncertainty. Semin Neonatol. 2002;7(5):361–367. doi:10.1053/siny.2002.0130.
  • Silverman WA. A cautionary tale about supplemental oxygen: the albatross of neonatal medicine. Pediatrics. 2004;113(2):394–396. doi:10.1542/peds.113.2.394.
  • Askie LM, Brocklehurst P, Darlow BA, et al. NeOProM: neonatal oxygenation prospective meta-analysis collaboration study protocol. BMC Pediatr. 2011;11(6). doi:10.1186/1471-2431-11-6.
  • Askie LM, Darlow BA, Davis PG, et al. Effects of targeting lower versus higher arterial oxygen saturations on death or disability in preterm infants. Cochrane Database Syst Rev. 2017; 4(4):CD011190. Published 2017 Apr 11. doi:10.1002/14651858.CD011190.pub2.
  • Saugstad OD, Aune D. Optimal oxygenation of extremely low birth weight infants: a meta-analysis and systematic review of the oxygen saturation target studies. Neonatology. 2014;105(1):55–63. doi:10.1159/000356561.
  • Schmidt B, Whyte RK, Asztalos EV, et al. Effects of targeting higher vs lower arterial oxygen saturations on death or disability in extremely preterm infants: a randomized clinical trial. JAMA. 2013;309(20):2111–2120.doi:10.1001/jama.2013.5555.
  • SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network, Carlo WA, Finer NN, et al. Target ranges of oxygen saturation in extremely preterm infants. N Engl J Med. 2010;362(21):1959–1969. doi:10.1056/NEJMoa0911781.
  • Cummings JJ, Polin RA, Watterberg KL. COMMITTEE ON FETUS AND NEWBORN. oxygen targeting in extremely low birth weight infants [published correction appears in pediatrics. 2016 Dec;138(6)]. Pediatrics. 2016;138(2):e20161576. doi:10.1542/peds.2016-1576.
  • Wilson EB. Probable inference, the law of succession, and statistical inference. J Am Stat Assoc. 1927;22(158):209–212. doi:10.1080/01621459.1927.10502953.
  • Early Treatment for Retinopathy of Prematurity Cooperative Group, Quinn GE, Dobson V, Davitt BV, et al. Progression of myopia and high myopia in the early treatment for retinopathy of prematurity study: findings at 4 to 6 years of age. J AAPOS. 2013;17(2):124–128. doi:10.1016/j.jaapos.2012.10.025.
  • Early Treatment for Retinopathy of Prematurity Cooperative Group, Davitt BV, Quinn GE, Wallace DK, et al. Astigmatism progression in the early treatment for retinopathy of prematurity study to 6 years of age. Ophthalmology. 2011;118(12):2326–2329. doi:10.1016/j.ophtha.2011.06.006.
  • Gilbert C, Fielder A, Gordillo L, et al. Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development: implications for screening programs. Pediatrics. 2005;115(5):e518–e525.doi:10.1542/peds.2004-1180.
  • Lassarre C, Hardouin S, Daffos F, Forestier F, Frankenne F, Binoux M. Serum insulin-like growth factors and insulin-like growth factor binding proteins in the human fetus. relationships with growth in normal subjects and in subjects with intrauterine growth retardation. Pediatr Res. 1991;29(3):219–225. doi:10.1203/00006450-199103000-00001.
  • Zepeda-Romero LC, Hård AL, Gomez-Ruiz LM, et al. Prediction of retinopathy of prematurity using the screening algorithm WINROP in a Mexican population of preterm infants. Arch Ophthalmol. 2012;130(6):720–723.doi:10.1001/archophthalmol.2012.215.
  • Hård AL, Löfqvist C, Fortes Filho JB, Procianoy RS, Smith L, Hellström A. Predicting proliferative retinopathy in a Brazilian population of preterm infants with the screening algorithm WINROP. Arch Ophthalmol. 2010;128(11):1432–1436. doi:10.1001/archophthalmol.2010.255.
  • Tarnow-Mordi W, Stenson B, Kirby A, et al. BOOST-II Australia and United Kingdom Collaborative Groups. Outcomes of two trials of oxygen-saturation targets in preterm infants. N Engl J Med. 2016;374(8):749–760.doi:10.1056/NEJMoa1514212.
  • Binenbaum G, Tomlinson LA. Postnatal growth and retinopathy of prematurity study: rationale, design, and subject characteristics. Ophthalmic Epidemiol. 2017;24(1):36–47. doi:10.1080/09286586.2016.1255765.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.